© 2022 MJH Life Sciences and Drug Topics. All rights reserved.
© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
November 18, 2022
CSL Behring's gene therapy, called EntranaDez, may be approved later this month. BioMarin, Pfizer, Bayer and Freeline Therapeutics also have gene therapies for hemophilia in development.
November 14, 2022
Findings from research presented at the American College of Chest Physicians suggest the importance of selecting the right biologic from the start.
October 12, 2022
Several drugs with novel mechanisms of action have been put on the pathway for speedier approval decisions by the FDA. Phase 2 and 3 trials are underway.
October 07, 2022
Early interventions might preserve lung function, particularly in younger patients with frequent asthma exacerbations, say authors.
October 05, 2022
Long-acting recombinant replacement factor gets favorable rating from multidisciplinary group. Gene therapy was viewed with some wariness.
August 25, 2022
Nonsteroidal topical agents and TYK2 inhibitors may join an already full armamentarium.